GCM
ABMD

Graham Capital Management’s Abiomed Inc ABMD Stock Holding History

Graham Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,832
Closed -$941K – 1443
2022
Q3 		$941K Sell
3,832
-902
-19% -$244K 0.04% 517
2022
Q2 		$1.17M Buy
4,734
+3,122
+194% +$842K 0.05% 387
2022
Q1 		$533K Buy
+1,612
New +$496K 0.02% 536

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Graham Capital Management's ABMD Position: Q4 2022 in Review

Graham Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,832 shares — an estimated $941K sold.

Graham Capital Management first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $1.17M in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Graham Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Graham Capital Management sold 3,832 Abiomed Inc shares in Q4 2022, an estimated $941K.
  • Graham Capital Management first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
  • Graham Capital Management's Abiomed Inc position peaked at $1.17M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Graham Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.